Bio-Rad Laboratories Reports Strong Sartorius AG Financials
Company Announcements

Bio-Rad Laboratories Reports Strong Sartorius AG Financials

Bio-Rad Laboratories (BIO) has released an update.

Bio-Rad Laboratories, Inc. has shared an update on its investment in Sartorius AG, revealing key financial figures for the year ending December 31, 2023. Sartorius AG reported a strong financial performance with current assets of €1.96 billion, non-current assets of €7.8 billion, and a net profit of €290 million. Their sales revenue reached €3.4 billion, with a significant operating cash flow of €853.6 million. This summary is based on Sartorius AG’s consolidated financial statements and is intended for general investor awareness.

For further insights into BIO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyEarly notable gainers among liquid option names on June 17th
TheFlyBio-Rad says will need to update prior long-term outlook given market conditions
TheFlyBio-Rad assumed with a Hold from Buy at Jefferies
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!